Patents by Inventor Kai Kopke

Kai Kopke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Transdermal therapeutic system
    Publication number: 20030044453
    Abstract: The invention relates to a transdermal therapeutic system for application to the skin and/or mucosa consisting of at least one active substance in the form of a solid dispersion in combination with at least one destructuring agent and/or at least one structuring agent in a common matrix.
    Type: Application
    Filed: August 2, 2002
    Publication date: March 6, 2003
    Inventors: Michael Dittgen, Sabine Fricke, Christoph Volkel, Kathrin Ahrens, Hagen Gerecke, Kai Kopke
  • TTS containing an antioxidant
    Patent number: 6335031
    Abstract: Pharmaceutical composition comprising (S)-N-ethyl-3-[1-dimethylamino)ethyl]-N-methyl-phenyl-carbamate in free base or acid addition salt form and an anti-oxidant. Said pharmaceutical compositions may be delivered to a patient using a transdermal delivery device.
    Type: Grant
    Filed: April 14, 1999
    Date of Patent: January 1, 2002
    Assignees: Novartis AG, LTS Lohmann Therapie-Systeme GmbH Co. KG
    Inventors: Bodo Asmussen, Michael Horstmann, Kai Köpke, Henricus L. G. M. Tiemessen, Steven Minh Dinh, Paul M. Gargiulo
  • TTS containing an antioxidant
    Publication number: 20010048938
    Abstract: Pharmaceutical composition comprising (S)-N-ethyl-3-[1-dimethylamino)ethyl]-N-methyl-phenyl-carbamate in free base or acid addition salt form and an anti-oxidant. Said pharmaceutical compositions may be delivered to a patient using a transdermal delivery device.
    Type: Application
    Filed: December 20, 2000
    Publication date: December 6, 2001
    Inventors: Bodo Asmussen, Michael Horstmann, Kai Kopke, Henricus L.G.M. Tiemessen, Steven Minh Dinh, Paul M. Gargiulo
  • TTS containing an antioxidant
    Patent number: 6316023
    Abstract: Pharmaceutical composition comprising (S)-N-ethyl-3-[1-dimethylamino)ethyl]-N-methyl-phenyl-carbamate in free base or acid addition salt form and an antioxidant. Said pharmaceutical compositions may be delivered to a patient using a transdermal delivery device.
    Type: Grant
    Filed: December 20, 2000
    Date of Patent: November 13, 2001
    Assignees: Novartis AG, LTS Lohmann Therapie-Systeme GmbH
    Inventors: Bodo Asmussen, Michael Horstmann, Kai Köpke, Henricus L. G. M. Tiemessen, Steven Minh Dinh, Paul M. Gargiulo
  • Transdermal compositions with enhanced skin penetration properties
    Publication number: 20010018073
    Abstract: The invention relates to a transdermal therapeutic system for application to the skin and/or mucosa consisting of at least one active substance in the form of a solid dispersion in combination with at least one destructuring agent and/or at least one structuring agent in a common matrix.
    Type: Application
    Filed: March 5, 2001
    Publication date: August 30, 2001
    Applicant: JENAPHARM GMBH & CO., KG
    Inventors: Michael Dittgen, Sabine Fricke, Christoph Volkel, Kathrin Ahrens, Hagen Gerecke, Kai Kopke
  • Transdermal compositions with enhanced skin penetration properties
    Patent number: 6238284
    Abstract: The invention relates to a transdermal therapeutic system for application to the skin and/or mucosa consisting of at least one active substance in the form of a solid dispersion in combination with at least one destructuring agent and/or at least one structuring agent in a common matrix.
    Type: Grant
    Filed: September 10, 1999
    Date of Patent: May 29, 2001
    Assignees: Jenapharm GmbH & Co. KG, LTS Lohmann Therapie-Systeme AG
    Inventors: Michael Dittgen, Sabine Fricke, Christoph Völkel, Kathrin Ahrens, Hagen Gerecke, Kai Köpke